Genzyme Mergers and Acquisitions Summary

Life Science Company

Genzyme has acquired 17 companies of its own, including 1 in the last 5 years. A total of 9 acquisitions came from private equity firms. It has also divested 3 assets.

Genzyme’s largest acquisition to date was in 2004, when it acquired ILEX Oncology for $1.0B. It’s largest disclosed sale occurred in 2010, when it sold Genzyme Genetics to Laboratory of America Holdings for $925M. Genzyme has acquired in 8 different US states, and 4 countries. The Company’s most targeted sectors include life science (75%) and medical products (25%).

Join Mergr and gain access to Genzyme’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

M&A Summary

  • M&A Total Activity15
    • M&A Buy Activity12
    • M&A Sell Activity3
  • Total Sectors Invested 2
  • Total Countries Invested 4
  • M&A Buy/Sell Connections 12
  • M&A Advisors 3

Genzyme Corp.

500 Kendall Street,
Cambridge, Massachusetts 02142
United States,
(617) 252-7500
www.genzyme.com

Genzyme is a global biotech company. Genzyme's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant and immune disease. Genzyme was formed in 1981 and is based in Cambridge, Massachusetts.


M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (0.0/yr) # 12 - - - - - 12
vol $4.4B $4.4B
Sell (0.0/yr) # 3 - - - - - 3
vol $1.2B $1.2B
  15

Most Recent M&A

Company Date Value Type
Caprelsa 2015-07-27 - Divestiture
, United Kingdom · www.caprelsarems.com
Genzyme Corp -Cholestagel(R) 2011-02-10 553K BRL Divestiture
, Ontario
Genzyme Genetics 2010-12-01 925M USD Divestiture
Cambridge, Massachusetts
Genzyme Corporation’s Diagnostic Product Division 2010-11-18 265M USD Divestiture
, United States
Bioenvision, Inc. 2007-10-23 345M USD Add-on Acquisition
New York City, New York · www.bioenvision.com
AnorMED Inc. 2006-10-17 580M USD Add-on Acquisition
Langley, British Columbia
Bone Care International, Inc. 2005-07-01 719M USD Add-on Acquisition
Middleton, Wisconsin
Verigen AG 2005-02-28 - Add-on Acquisition
Leverkusen, Germany
ILEX Oncology, Inc. 2004-12-21 1.0B USD Add-on Acquisition
San Antonio, Texas
SangStat Medical Corp. 2003-09-10 600M USD Add-on Acquisition
Fremont, California
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 9 (75%) 4.1B (94%) 1 (33%) 925M (78%)
Medical Products 3 (25%) 261M (6%) 1 (33%) 553K (< 1%)
Healthcare Services - - 1 (33%) 265M (22%)
Total 12 $4.4B 3 $1.2B

By Geo

State/Country Buy Value Sell Value
United States 9 3.8B 2 1.2B
  Massachusetts 2 250M 1 925M
  Wisconsin 1 719M - -
  Texas 1 1.0B - -
  Oklahoma 1 137M - -
  New York 1 345M - -
  New Jersey 1 738M - -
  California 1 600M - -
Canada 1 580M 1 553K
  British Columbia 1 580M - -
  Ontario - - 1 553K
Germany 1 - - -
United Kingdom 1 - - -
Domestic 9 (75%) 3.8B (87%) 2 (67%) 1.2B (100%)
Cross-border 3 (25%) 580M (13%) 1 (33%) 553K (< 1%)
Total 12 $4.4B 3 $1.2B

Top M&A Advisors

Financial Deals
Credit Suisse Investment Banking
1
UBS Investment Bank
1
Legal Deals
Ropes & Gray LLP
1

Deal Values

buy # Total
> $1B 1 $1.0B
$100M to $1B 7 $3.4B
< $100M 1 $11M
TOTAL $4.4B
Largest ILEX Oncology, Inc.
$1.0B (2004-12-21)
sell # Total
$100M to $1B 2 $1.2B
< $100M 1 $553K
TOTAL $1.2B
Largest Genzyme Genetics
$925M (2010-12-01)

M&A Connections

Deals %
Acquired from
PE Firm(s)
82%
9 82%
Strategic(s)
18%
2 18%
Divested to
Strategic(s)
100%
3 100%

 Subscribe to unlock this and 153,348
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.9K Private Equity Firms
  • 141K M&A Transactions
  • 149K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.1K M&A Advisors
    (Investment Banks and Law Firms)
  • 42K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.